The AAP leader's remarks came a day after British pharma giant AstraZeneca admitted in a UK court that its anti-COVID vaccine sold globally as Covishield and Vaxzevria may cause Thrombocytopenia Syndrome (TTS) in "very rare cases."
UK-headquartered pharmaceutical giant AstraZeneca, under scanner over potential side effects associated with its COVID-19 vaccine, has reiterated its commitment to patient safety after acknowledging that the vaccine can, in "very rare cases", cause a blood clot related side effect amongst those administered its vaccine., India News - Times Now
The petitioner sought the setting up of a committee of expert medical doctors from AIIMS, Delhi, to examine the side effects and the risk factors involved in the vaccination.
The plea was filed after manufacturer Astrazeneca admitted before a court in the United Kingdom that COVISHIELD has the potential to cause a rare side effect associated with blood clotting.
Four new side effects linked with AstraZeneca also known as Covisheild in India have been listed by the experts. See if you have any of them. TheHealthSite.com